Latest News & Updates
Breaking News
5 minutes ago
Simantini Singh Deo
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Immutep Limited Wins FDA Orphan Drug Designation For Cancer Drug Eftilagimod Alfa In Soft Tissue Sarcoma
Immutep Limited secures FDA Orphan Drug Designation for eftilagimod alfa, advancing its immunotherapy for soft tissue sarcoma supported by positive Phase II clinical trial results.
Simantini Singh Deo
Arbutus Biopharma Corporation Wins FDA Fast Track Status For Chronic Hepatitis B Drug Imdusiran
Arbutus Biopharma Corporation gains FDA Fast Track designation for imdusiran, advancing development of its investigational therapy for chronic hepatitis B with encouraging clinical outcomes.
Simantini Singh Deo
Aerska Strengthens Scientific And Operational Capabilities To Push Forward Brain-Targeted RNAi Platform
Aerska appoints Stuart Milstein and Lisa Taylor Ash to strengthen its RNAi platform, advancing brain-targeted therapies for central nervous system diseases toward clinical development.
Simantini Singh Deo
Caldolor IV Ibuprofen Wins FDA Expanded Indication, Shifting Hospital Formulary Calculus
Cumberland Pharmaceuticals secures expanded FDA indication for Caldolor IV ibuprofen, prompting formulary and protocol review at acute-care facilities.
Pharma Now Editorial Team
